COMP <GO>
BDX vs DXCM // FORWARD P/E MULTIPLE
Becton Dickinson and Company (NYSE) VS. DexCom Inc. (NASDAQ) • 15-METRIC TALLY: BDX 5
— DXCM 9
▲ FORWARD P/E MULTIPLE LEADER: BDX
LAST: $198.34 (+1.63%) • MKT CAP: $54.03B
forward-pe
29.9x
LAST: $79.93 (+1.67%) • MKT CAP: $30.16B
forward-pe
30.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDX VS. DXCM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BDX | DXCM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.40% | 60.10% | -14.70 | DXCM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.90% | 21.60% | -16.70 | DXCM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.8x | 25.2x | -3.40 | BDX | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 3.57% | -1.44 | DXCM | /fcf-yield <GO> |
| Operating Margin | 11.80% | 19.60% | -7.80 | DXCM | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 17.90% | -10.20 | DXCM | /net-margins <GO> |
| Revenue Growth (YoY) | 8.20% | 15.60% | -7.40 | DXCM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.21% | 0.00% | +2.21 | BDX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 7.14 | -4.92 | DXCM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | DXCM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.6 | 41.8 | +22.80 | BDX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.10 | -0.04 | DXCM | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 29.9x | 30.3x | -0.40 | BDX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $54.03B | $30.16B | $23.86B | BDX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BDX REV | DXCM REV | BDX GROSS % | DXCM GROSS % | BDX FCF | DXCM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.84B | $4.66B | 45.4% | 60.1% | — | $1.08B |
| FY 2024 | $20.18B | $4.03B | 45.2% | 60.5% | — | $630.7M |
| FY 2023 | $19.37B | $3.62B | — | — | — | $585.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDX // BETA 1.06
DXCM // BETA 1.10